These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


121 related items for PubMed ID: 15067959

  • 1. [PET Scan in the work-up of NSCLC].
    Fornito MC.
    Suppl Tumori; 2004; 3(2):S21-4. PubMed ID: 15067959
    [No Abstract] [Full Text] [Related]

  • 2. PET scanning said to save money and improve staging of lung cancer.
    Oncology (Williston Park); 1995 Nov; 9(11):1200. PubMed ID: 8703689
    [No Abstract] [Full Text] [Related]

  • 3. 18Fluorodeoxyglucose positron emission tomography, a standard diagnostic tool in lung cancer.
    Giaccone G.
    J Natl Cancer Inst; 2007 Dec 05; 99(23):1741-3. PubMed ID: 18042929
    [No Abstract] [Full Text] [Related]

  • 4. [Positron-emission tomography in the evaluation of lung cancer].
    Torres García AJ, Carreras Delgado JL.
    Arch Bronconeumol; 1997 Dec 05; 33(11):553-5. PubMed ID: 9508470
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?
    Aquino SL, Fischman AJ.
    Chest; 2004 Sep 05; 126(3):755-60. PubMed ID: 15364753
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Use of positron-emission tomography with F18-fluorodeoxyglucose for the assessment of lung lesions suspicious of malignancy].
    Jofré MJ, Massardo T, González P, Canessa J, Sierralta P, Humeres P, Galaz R, Valdebenito R.
    Rev Med Chil; 2005 May 05; 133(5):583-92. PubMed ID: 15970984
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Response to radiation.
    Rosenzweig KE, Fox JL, Giraud P.
    Semin Radiat Oncol; 2004 Oct 05; 14(4):322-5. PubMed ID: 15558507
    [Abstract] [Full Text] [Related]

  • 12. [Solitary pulmonary nodule without diagnosis: is it indication for F-18-fluoro-deoxyglucose scintigraphy (18-FDG-PET-SCAN)?].
    Vaylet F.
    Rev Mal Respir; 2004 Feb 05; 21(1):221-2. PubMed ID: 15260075
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Positron emission tomography with CT in the evaluation of non-small cell lung cancer in populations with a high prevalence of tuberculosis.
    Low SY, Eng P, Keng GH, Ng DC.
    Respirology; 2006 Jan 05; 11(1):84-9. PubMed ID: 16423207
    [Abstract] [Full Text] [Related]

  • 18. Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer.
    Lardinois D, Weder W, Roudas M, von Schulthess GK, Tutic M, Moch H, Stahel RA, Steinert HC.
    J Clin Oncol; 2005 Oct 01; 23(28):6846-53. PubMed ID: 16192576
    [Abstract] [Full Text] [Related]

  • 19. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging.
    Antoch G, Stattaus J, Nemat AT, Marnitz S, Beyer T, Kuehl H, Bockisch A, Debatin JF, Freudenberg LS.
    Radiology; 2003 Nov 01; 229(2):526-33. PubMed ID: 14512512
    [Abstract] [Full Text] [Related]

  • 20. PET in lung cancer staging.
    Coleman RE.
    Q J Nucl Med; 2001 Sep 01; 45(3):231-4. PubMed ID: 11788815
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.